Targeting mucin hypersecretion in COVID-19 therapy. | Future Med Chem;14(10): 681-684, 2022 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Targeting mucin hypersecretion in COVID-19 therapy.

Prasher, Parteek; Sharma, Mousmee.

Prasher P; Department of Chemistry, UGC Sponsored Centre for Advanced Studies, Guru Nanak Dev University, Amritsar, 143005, India.
Sharma M; Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, 248007, India.

Future Med Chem ; 14(10): 681-684, 2022 05.

Article in English | MEDLINE | ID: covidwho-1753807

Subject(s)

COVID-19 Drug Treatment; Humans; Mucins; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; mucins

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Future Med Chem Year: 2022 Document Type: Article Affiliation country: Fmc-2021-0111

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Future Med Chem Year: 2022 Document Type: Article Affiliation country: Fmc-2021-0111